Advancing Urological Care with Aquablation: A Comprehensive Guide for Physicians

Steve Sterious, MD, FACS, Fox Chase-Temple Urologic Institute Provider, is a nationally recognized leader in the treatment of Aquablation for benign prostatic hyperplasia (BPH). He collaborated on the largest multi-institutional international trials in Aquablation. During this video, Sterious will review what Aquablation is best used for, including the accuracy and effectiveness in improving the quality of life for patients.

Throughout the presentation, Sterious will describe the outcomes of various clinical trials, including a comparison to other treatments for BPH, like Transurethral Resection of the Prostate (TURP). The overall outcomes have shown that Aquablation provides patients with fewer complications, like erectile dysfunction and is preferred for treatment of larger prostates due to the precision of the water jets.

Created by

Temple Health


Steve Sterious, MD, FACS

Steve Sterious, MD, FACS

Professor, Urology/Urologic Oncology, Fox Chase Cancer Center
Fox Chase-Temple Urologic Institute Provider

Clinical Interests Minimally invasive surgery Robotic surgery Benign prostatic hyperplasia: urolift, rezum, aquablation, greenlight, transurethral resection of the prostate Kidney stone surgery Erectile dysfunction and hypogonadism ...

View full profile